Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.

Key Points

• This research aims to evaluate the effectiveness and safety of hypofractionated radiotherapy for prostate cancer.
• Compared clinical outcomes of hypofractionated radiotherapy with conventionally fractionated radiotherapy
• Evaluated patient populations with low- to intermediate-risk prostate cancer
• Assessed toxicity profiles alongside oncological outcomes
• Hypofractionated radiotherapy demonstrated comparable oncological outcomes to conventional methods
• The toxicity profile was deemed acceptable in treated patients

Abstract